Combining physiological signals does not guarantee a larger response. This experiment used repeated visits to investigate interactions in the reproductive pulse-generating system. Primary report
Study snapshot
Five healthy men attended eight visits with different kisspeptin-54, neurokinin-B, naltrexone, and control combinations. Kisspeptin- and naltrexone-containing conditions increased LH-related measures. Neurokinin B alone did not change gonadotropins, and adding it to kisspeptin reduced the gonadotropin increase relative to kisspeptin alone. LH pulsatility was estimated by blinded deconvolution. Primary report
Our appraisal: interactions need direct contrasts
A component can behave differently alone and in a combination. That is why the relevant comparison is not merely each arm versus control; the combined arm must also be compared with its components. A simple additive story would miss the reported attenuation.
Repeated visits help control stable differences between participants, but introduce questions about visit order, washout, and carryover. Five people attending many visits are still five independent participants for population generalization.
Pulse detection also depends on a model. Sampling frequency, assay precision, and deconvolution assumptions affect estimated pulse characteristics. Blinding the analysis is useful but does not eliminate the need to inspect those assumptions.
The study probes a physiological hypothesis, not the effectiveness of a commercial blend or an infertility treatment. Full review should preserve the visit structure, direct interaction comparisons, multiplicity handling, and the distinction between measured LH and inferred upstream signaling. The useful conclusion is that interacting signals require empirical testing; their names or individual effects do not predict the combination automatically.
Frequently asked questions
Were eight independent groups of many men recruited?
No; five men attended repeated study visits.
Did neurokinin B alone increase gonadotropins?
Not in the reported comparison.
Did adding neurokinin B necessarily strengthen kisspeptin's response?
No.
Was pulsatility estimated analytically?
Yes, by deconvolution.
Do repeated visits remove all design concerns?
No; order and carryover still matter.
Does this validate a peptide blend?
No.
What is the principal lesson?
Combination effects must be measured rather than assumed from component effects.